MSF challenges Pfizer's India vaccine patent application

March 12, 2016

Doctors Without Borders has challenged Pfizer's application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organizations.

The medical aid group, also known as Medicins Sans Frontieres, said in a statement late Friday that it was challenging Pfizer's patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.

If Pfizer is granted a patent for the vaccine, Indian drug companies would not be able to make cheaper generic versions.

"The pneumonia vaccine is the world's best-selling vaccine, and last year alone, Pfizer brought in more than $6 billion in sales just for this product," Dr. Manica Balasegaram, Executive Director of MSF's Access Campaign, said in the statement. "Meanwhile, many developing countries, where millions of children risk getting pneumonia, simply can't afford it."

"To make sure children everywhere can be protected from deadly pneumonia, other companies need to enter the market to supply this vaccine for a much lower price than what Pfizer charges," Balasegaram said.

Doctors Without Borders said its decision to oppose New-York based Pfizer's patent application comes after "years of fruitless negotiations" to get the company to reduce the price of the drug for use in humanitarian projects.

Pfizer India said Saturday that the company had not yet received a copy of the patent opposition, and that it was in talks with Indian health officials to try to assess local needs.

Pneumonia kills almost a million children each year.

"As doctors who have watched far too many children die of pneumonia, we're not going to back down until we know that all countries can afford this vaccine," Balasegaram said.

Explore further: Pfizer stops China vaccine sales as import license expires

Related Stories

Pfizer stops China vaccine sales as import license expires

April 2, 2015
Pfizer has stopped selling its Prevnar 7 pneumonia vaccine in China after its import license expired, but the U.S. drugmaker still intends to launch the world's most widely used vaccine, Prevnar 13, in that market.

Prevnar, Pfizer's pneumonia vaccine, okayed for adults in EU

March 3, 2015
Pfizer's blockbuster vaccine against pneumonia and other bacterial infections has won another approval, for use in European Union residents aged 18 and older.

Pfizer adds $784.6 M charge for Protonix deal to 4Q results

February 16, 2016
Drugmaker Pfizer Inc. swung to a fourth-quarter financial loss, instead of a modest profit, as a result of a just-announced charge to settle a long-running federal case over reimbursements for its former blockbuster heartburn ...

Pfizer closes $635M vaccines purchase from Baxter

December 1, 2014
Pfizer has completed its $635 million purchase from Baxter International Inc. of two vaccines and part of the factory in Orth, Austria, where they're made.

Study finds Pfizer vaccine cuts pneumonia in elderly

March 12, 2014
Pfizer Inc. said Wednesday that its blockbuster vaccine against pneumonia, blood and other infections met its goal of preventing illness in vulnerable elderly patients in a huge study required by U.S. regulators.

Recommended for you

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

Opioids overused in migraine treatment, regardless of race, study finds

August 17, 2017
African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices.

Finding better ways to reduce serious drug side effects

August 14, 2017
Many of the medicines we depend on to treat disease—and even to save our lives—pose potentially serious risks along with their benefits. Data from the U.S. Centers for Disease Control and Prevention indicate that about ...

Ultrasound-triggered liposomes for on-demand, local anesthesia

August 10, 2017
Researchers at Boston Children's Hospital have found a new way to non-invasively relieve pain at local sites in the body; such systems could one day improve pain management by replacing addictive opioids and short-lasting ...

Independent pharmacies and online coupons help patients save money on drugs

August 8, 2017
Uninsured patients or those with limited prescription drug coverage can save significant money by buying their drugs at independent pharmacies instead of big box, grocery or chain drug stores and by using discount coupons, ...

New study generates more accurate estimates of state opioid and heroin fatalities

August 7, 2017
Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings. Further complicating the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.